Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HOMA-IR in acromegaly: a systematic review and meta-analysis.
Biagetti B, Aulinas A, Casteras A, Pérez-Hoyos S, Simó R. Biagetti B, et al. Among authors: casteras a. Pituitary. 2021 Apr;24(2):146-158. doi: 10.1007/s11102-020-01092-6. Epub 2020 Oct 21. Pituitary. 2021. PMID: 33085039
Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma.
Iglesias P, Biagetti B, Araujo-Castro M, Alcázar V, Guerrero-Pérez F, Rivero N, Casteràs A, Gómez CG, Izquierdo BG, Torres VV, Pascual-Corrales E, Pavón I, Villabona C, Cordido F, Díez JJ. Iglesias P, et al. Among authors: casteras a. J Neurooncol. 2022 Nov;160(2):351-359. doi: 10.1007/s11060-022-04149-7. Epub 2022 Nov 10. J Neurooncol. 2022. PMID: 36355257
Clinical Significance of T2-Weighted Sequence Intensity on Magnetic Resonance Imaging in Clinically Non-Functioning Pituitary Adenomas.
Iglesias P, Biagetti B, Araujo-Castro M, Alcázar V, Guerrero-Pérez F, Rivero N, Casteràs A, Gómez CG, Izquierdo BG, Torres VV, Pascual-Corrales E, Pavón I, Villabona C, Cordido F, Díez JJ. Iglesias P, et al. Among authors: casteras a. Exp Clin Endocrinol Diabetes. 2023 Dec;131(12):631-638. doi: 10.1055/a-2197-3566. Epub 2023 Dec 6. Exp Clin Endocrinol Diabetes. 2023. PMID: 38056490
Long-term improvement of metabolic control without increased risk of hypoglycaemia by intensive insulin regimens in type 1 diabetes patients treated in a regular clinical setting.
Pérez Méndez LF, Alvarez-García E, Alvarez-Vázquez P, Hervás E, Casterás A, Fajar L, García-Mayor RV. Pérez Méndez LF, et al. Among authors: casteras a. Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):182-6. doi: 10.1055/s-2007-956165. Exp Clin Endocrinol Diabetes. 2007. PMID: 17427108
25 results